Found 7 matching trials
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer PHASE4 The primary purpose of this study is to determine the optimal duration of a...
Show More Location
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
Learn More & Join Trial
Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation NA This is a prospective, single-center, randomized, exploratory clinical obse...
Show More Location
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Learn More & Join Trial
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT PHASE4 After hip or knee replacement all patients receive a standardized treatment...
Show More Location
Gelre Ziekenhuizen
Learn More & Join Trial
Effect of Apiban Therapy on AVF Maturation in ESRD Patients NA End-stage renal disease (ESRD) is a growing global health burden, and the c...
Show More Location
Combined Military Hospital, Lahore
Learn More & Join Trial
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure PHASE4 The objective of the study is to compare short-term (8 weeks) anticoagulati...
Show More Status
Active Not Recruiting
Location
Josep Rodes-Cabau
Learn More & Join Trial
Prague Registry of Electric Cardioversion N/A This single-center observational registry follows contemporary efficacy and...
Show More Location
Institute for Clinical and Experimental Medicine (IKEM)
Learn More & Join Trial
Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy PHASE4 This study is designed to find out if it is safe to keep taking blood-thinn...
Show More Status
Active Not Recruiting
Location
Clínica Rotger Quirónsalud
Learn More & Join Trial